Cargando…
Nanobody-based pannexin1 channel inhibitors reduce inflammation in acute liver injury
BACKGROUND: The opening of pannexin1 channels is considered as a key event in inflammation. Pannexin1 channel-mediated release of adenosine triphosphate triggers inflammasome signaling and activation of immune cells. By doing so, pannexin1 channels play an important role in several inflammatory dise...
Autores principales: | Van Campenhout, Raf, De Groof, Timo W. M., Kadam, Prashant, Kwak, Brenda R., Muyldermans, Serge, Devoogdt, Nick, Vinken, Mathieu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566086/ https://www.ncbi.nlm.nih.gov/pubmed/37821897 http://dx.doi.org/10.1186/s12951-023-02137-1 |
Ejemplares similares
-
Therapeutic Nanobodies Targeting Cell Plasma Membrane Transport Proteins: A High-Risk/High-Gain Endeavor
por: Van Campenhout, Raf, et al.
Publicado: (2021) -
Mechanisms Underlying Connexin Hemichannel Activation in Disease
por: Van Campenhout, Raf, et al.
Publicado: (2021) -
Pannexin1 channels in the liver: an open enemy
por: Van Campenhout, Raf, et al.
Publicado: (2023) -
Effects of Drugs Formerly Suggested for COVID-19 Repurposing on Pannexin1 Channels
por: Caufriez, Anne, et al.
Publicado: (2022) -
Increased Expression of Adherens Junction Components in Mouse Liver following Bile Duct Ligation
por: Van Campenhout, Raf, et al.
Publicado: (2019)